Predicted Trait | |
Reported Trait | ZEBRA antigen for Epstein-Barr Virus |
Mapped Trait(s) | anti-Epstein Barr virus antibody measurement (EFO_0009273) |
Additional Trait Information | https://biobankengine.stanford.edu/RIVAS_HG19/snpnet/INI23005 |
Score Construction | |
PGS Name | GBE_INI23005 |
Development Method | |
Name | snpnet |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 158 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000244 |
Citation (link to publication) | Tanigawa Y et al. PLoS Genet (2022) |
Ancestry Distribution | |
Score Development/Training | European: 100% 5,368 individuals (100%) |
PGS Evaluation | European: 40% African: 20% East Asian: 20% South Asian: 20% 5 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | 5,368 individuals | European | UKB | — | — | — | white British ancestry | Training + validation cohort (train_val) |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM005340 | PSS005016| African Ancestry| 119 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: ZEBRA antigen for Epstein-Barr Virus | — | — | R²: 0.13241 [0.11706, 0.14775] Incremental R2 (full-covars): 0.0307 PGS R2 (no covariates): 0.04734 [0.03727, 0.05742] |
age, sex, UKB array type, Genotype PCs | — |
PPM005341 | PSS005017| East Asian Ancestry| 41 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: ZEBRA antigen for Epstein-Barr Virus | — | — | R²: 0.42791 [0.39244, 0.46337] Incremental R2 (full-covars): 0.00179 PGS R2 (no covariates): 0.02952 [0.01372, 0.04533] |
age, sex, UKB array type, Genotype PCs | — |
PPM005342 | PSS005018| European Ancestry| 471 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: ZEBRA antigen for Epstein-Barr Virus | — | — | R²: 0.07688 [0.07052, 0.08324] Incremental R2 (full-covars): 0.02635 PGS R2 (no covariates): 0.02765 [0.02363, 0.03166] |
age, sex, UKB array type, Genotype PCs | — |
PPM005343 | PSS005019| South Asian Ancestry| 164 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: ZEBRA antigen for Epstein-Barr Virus | — | — | R²: 0.15445 [0.13974, 0.16917] Incremental R2 (full-covars): -0.01516 PGS R2 (no covariates): 0.00397 [0.00119, 0.00675] |
age, sex, UKB array type, Genotype PCs | — |
PPM005344 | PSS005020| European Ancestry| 1,275 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: ZEBRA antigen for Epstein-Barr Virus | — | — | R²: 0.05788 [0.05445, 0.0613] Incremental R2 (full-covars): 0.03995 PGS R2 (no covariates): 0.03909 [0.03622, 0.04196] |
age, sex, UKB array type, Genotype PCs | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS005020 | — | — | 1,275 individuals | — | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS005016 | — | — | 119 individuals | — | African unspecified | — | UKB | — |
PSS005017 | — | — | 41 individuals | — | East Asian | — | UKB | — |
PSS005018 | — | — | 471 individuals | — | European | non-white British ancestry | UKB | — |
PSS005019 | — | — | 164 individuals | — | South Asian | — | UKB | — |